Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents
Circulation Research. 1979;44:127-137

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reivich, M.
Right arrow Articles by Sokoloff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reivich, M.
Right arrow Articles by Sokoloff, L.

Circulation Research, Vol 44, 127-137, Copyright © 1979 by American Heart Association

ARTICLES

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

M Reivich, D Kuhl, A Wolf, J Greenberg, M Phelps, T Ido, V Casella, J Fowler, E Hoffman, A Alavi, P Som and L Sokoloff

A method has been developed to measure local glucose consumption in the various structures of the brain in man with three-dimensional resolution. [18F]-2-deoxy-2-fluoro-D-glucose is used as a tracer for the exchange of glucose between plasma and brain and its phosphorylation by hexokinase in the tissue. A mathematical model and derived operational equation are used which enable local cerebral glucose consumption to be calculated in terms of the following measurable variables. An intravenous bolus of [18F]-2-deoxy-2-fluoro-D- glucose is given and the arterial specific activity monitored for a predetermined period of from 30 to 120 minutes. Starting at 30 minutes, the activity in a series of sections through the brain is determined with three-dimensional resolution by an emission tomographic scanner. The method was used to measure local cerebral glucose consumption in two normal volunteers. The values in gray matter structures range from 5.79 mg/100 g per minute in the cerebellar cortex to 10.27 in the visual cortex, whereas, in white matter structures, the values range from 3.64 mg/100 g per minute in the corpus callosum to 4.22 in the occipital lobe. Average values for gray matter, white matter, and whole brain metabolic rates, calculated as a weighted average based on the approximate volume of each structure, are 8.05, 3.80, and 5.90 mg/100 g per minute, respectively. The value of 5.9 mg/100 g per minute compares favorably with values previously reported.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. Bauer, D. H. S. Silverman, F. Schlagenhauf, E. D. London, C. L. Geist, K. van Herle, N. Rasgon, D. Martinez, K. Miller, A. van Herle, et al.
Brain Glucose Metabolism in Hypothyroidism: A Positron Emission Tomography Study before and after Thyroid Hormone Replacement Therapy
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2922 - 2929.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. R. Zazulia, T. O. Videen, and W. J. Powers
Transient Focal Increase in Perihematomal Glucose Metabolism After Acute Human Intracerebral Hemorrhage
Stroke, May 1, 2009; 40(5): 1638 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J J Virta, S Aalto, T Jarvenpaa, M Karrasch, J Kaprio, M Koskenvuo, I Raiha, T Viljanen, and J O Rinne
Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease
J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 259 - 266.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
O. S. Tehrani, O. Muzik, L. K. Heilbrun, K. A. Douglas, J. M. Lawhorn-Crews, H. Sun, T. J. Mangner, and A. F. Shields
Tumor Imaging Using 1-(2'-deoxy-2'-18F- Fluoro-{beta}-D-Arabinofuranosyl)Thymine and PET
J. Nucl. Med., September 1, 2007; 48(9): 1436 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. A. Mankoff, J. F. Eary, J. M. Link, M. Muzi, J. G. Rajendran, A. M. Spence, and K. A. Krohn
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Clin. Cancer Res., June 15, 2007; 13(12): 3460 - 3469.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. J. Laschet, I. Kurcewicz, F. Minier, S. Trottier, J. Khallou-Laschet, J. Louvel, S. Gigout, B. Turak, A. Biraben, J.-M. Scarabin, et al.
Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy
PNAS, February 27, 2007; 104(9): 3472 - 3477.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Tokugawa, L. Ravasi, T. Nakayama, K. C. Schmidt, and L. Sokoloff
Operational Lumped Constant for FDG in Normal Adult Male Rats
J. Nucl. Med., January 1, 2007; 48(1): 94 - 99.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W. P. Dillon, J. D. Eastwood, T. C. Glenn, C. B. Grandin, S. Pedraza, J.-F. Soustiel, et al.
Comparative Overview of Brain Perfusion Imaging Techniques
Stroke, September 1, 2005; 36(9): e83 - e99.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. S. Mega, I. D. Dinov, V. Porter, G. Chow, E. Reback, P. Davoodi, S. M. O'Connor, M. F. Carter, H. Amezcua, and J. L. Cummings
Metabolic Patterns Associated With the Clinical Response to Galantamine Therapy: A Fludeoxyglucose F 18 Positron Emission Tomographic Study
Arch Neurol, May 1, 2005; 62(5): 721 - 728.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W.-D. Heiss, B. Habedank, J. C. Klein, K. Herholz, K. Wienhard, M. Lenox, and R. Nutt
Metabolic Rates in Small Brain Nuclei Determined by High-Resolution PET
J. Nucl. Med., November 1, 2004; 45(11): 1811 - 1815.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
F. Pain, P. Laniece, R. Mastrippolito, P. Gervais, P. Hantraye, and L. Besret
Arterial Input Function Measurement Without Blood Sampling Using a {beta}-Microprobe in Rats
J. Nucl. Med., September 1, 2004; 45(9): 1577 - 1582.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. L.J. Dearling, A. A. Flynn, J. Sutcliffe-Goulden, I. A. Petrie, R. Boden, A. J. Green, G. M. Boxer, R. H.J. Begent, and R. B. Pedley
Analysis of the Regional Uptake of Radiolabeled Deoxyglucose Analogs in Human Tumor Xenografts
J. Nucl. Med., January 1, 2004; 45(1): 101 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
E. D. London, S. L. Simon, S. M. Berman, M. A. Mandelkern, A. M. Lichtman, J. Bramen, A. K. Shinn, K. Miotto, J. Learn, Y. Dong, et al.
Mood Disturbances and Regional Cerebral Metabolic Abnormalities in Recently Abstinent Methamphetamine Abusers
Arch Gen Psychiatry, January 1, 2004; 61(1): 73 - 84.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
B. Schaller, R. Graf, Y. Sanada, M. Tolnay, G. Rosner, K. Wienhard, and W.-D. Heiss
Hemodynamic Changes after Occlusion of the Posterior Superior Sagittal Sinus: An Experimental PET Study in Cats
AJNR Am. J. Neuroradiol., October 1, 2003; 24(9): 1876 - 1880.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Yoshioka, K. Yamaguchi, K. Kubota, T. Saginoya, T. Yamazaki, T. Ido, G. Yamaura, H. Takahashi, H. Fukuda, and R. Kanamaru
Evaluation of 18F-FDG PET in Patients with Advanced, Metastatic, or Recurrent Gastric Cancer
J. Nucl. Med., May 1, 2003; 44(5): 690 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
D. L. Sultzer, C. V. Brown, M. A. Mandelkern, M. E. Mahler, M. F. Mendez, S. T. Chen, and J. L. Cummings
Delusional Thoughts and Regional Frontal/Temporal Cortex Metabolism in Alzheimer's Disease
Am J Psychiatry, February 1, 2003; 160(2): 341 - 349.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
D. L. Sultzer, S. T. Chen, C. V. Brown, M. E. Mahler, J. L. Cummings, C. H. Hinkin, and M. A. Mandelkern
Subcortical Hyperintensities in Alzheimer's Disease: Associated Clinical and Metabolic Findings
J Neuropsychiatry Clin Neurosci, August 1, 2002; 14(3): 262 - 269.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. Herholz, H. Schopphoff, M. Schmidt, R. Mielke, W. Eschner, K. Scheidhauer, H. Schicha, W.-D. Heiss, and K. Ebmeier
Direct Comparison of Spatially Normalized PET and SPECT Scans in Alzheimer's Disease
J. Nucl. Med., January 1, 2002; 43(1): 21 - 26.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. I. Wiebe
FDG Metabolism: Quaecumque Sunt Vera ...
J. Nucl. Med., November 1, 2001; 42(11): 1679 - 1681.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. G. Shulman
Functional Imaging Studies: Linking Mind and Basic Neuroscience
Am J Psychiatry, January 1, 2001; 158(1): 11 - 20.
[Abstract] [Full Text]

Home page
 J Child NeurolHome page
J. Rudolf, M. Grond, M. Planck, D. Schindler, W.-D. Heiss, and R. J. Desnick
Cerebral Glucose Metabolism in Type I {alpha}-N-Acetylgalactosaminidase Deficiency: An Infantile Neuroaxonal Dystrophy
J Child Neurol, August 1, 1999; 14(8): 543 - 547.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. G. Shulman and D. L. Rothman
Interpreting functional imaging studies in terms of neurotransmitter cycling
PNAS, September 29, 1998; 95(20): 11993 - 11998.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. E. Raichle
Behind the scenes of functional brain imaging: A historical and physiological perspective
PNAS, February 3, 1998; 95(3): 765 - 772.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
W.-D. Heiss, M. Grond, A. Thiel, M. Ghaemi, J. Sobesky, J. Rudolf, B. Bauer, and K. Wienhard
Permanent Cortical Damage Detected by Flumazenil Positron Emission Tomography in Acute Stroke
Stroke, February 1, 1998; 29(2): 454 - 461.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
W.-D. Heiss, R. Graf, T. Fujita, K. Ohta, B. Bauer, J. Lottgen, and K. Wienhard
Early Detection of Irreversibly Damaged Ischemic Tissue by Flumazenil Positron Emission Tomography in Cats
Stroke, October 1, 1997; 28(10): 2045 - 2052.
[Abstract] [Full Text]

Home page
 Arch Gen PsychiatryHome page
R. E. Gur, P. D. Mozley, S. M. Resnick, L. H. Mozley, D. L. Shtasel, F. Gallacher, S. E. Arnold, J. S. Karp, A. Alavi, M. Reivich, et al.
Resting Cerebral Glucose Metabolism in First-Episode and Previously Treated Patients With Schizophrenia Relates to Clinical Features
Arch Gen Psychiatry, August 1, 1995; 52(8): 657 - 667.
[Abstract] [PDF]

Home page
 JAMAHome page
G. W. Small, J. C. Mazziotta, M. T. Collins, L. R. Baxter, M. E. Phelps, M. A. Mandelkern, A. Kaplan, A. La Rue, C. F. Adamson, L. Chang, et al.
Apolipoprotein E Type 4 Allele and Cerebral Glucose Metabolism in Relatives at Risk for Familial Alzheimer Disease
JAMA, March 22, 1995; 273(12): 942 - 947.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
H. Karbe, J. Kessler, K. Herholz, G. R. Fink, and W.-D. Heiss
Long-term Prognosis of Poststroke Aphasia Studied With Positron Emission Tomography
Arch Neurol, February 1, 1995; 52(2): 186 - 190.
[Abstract] [PDF]

Home page
 Stat Methods Med ResHome page
J. McColl, A. Holmes, and I. Ford
Statistical methods in neuroimaging with particular application to emission tomography
Statistical Methods in Medical Research, March 1, 1994; 3(1): 63 - 86.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
W.-D. Heiss, J. Kessler, H. Karbe, G. R. Fink, and G. Pawlik
Cerebral Glucose Metabolism as a Predictor of Recovery From Aphasia in Ischemic Stroke
Arch Neurol, September 1, 1993; 50(9): 958 - 964.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
G. W. Small, A. F. Leuchter, M. A. Mandelkern, A. L. Rue, A. Okonek, R. B. Lufkin, L. F. Jarvik, S. S. Matsuyama, and W. Bondareff
Clinical, Neuroimaging, and Environmental Risk Differences in Monozygotic Female Twins Appearing Discordant for Dementia of the Alzheimer Type
Arch Neurol, February 1, 1993; 50(2): 209 - 219.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
L. R. Baxter Jr, J. M. Schwartz, K. S. Bergman, M. P. Szuba, B. H. Guze, J. C. Mazziotta, A. Alazraki, C. E. Selin, H.-K. Ferng, P. Munford, et al.
Caudate Glucose Metabolic Rate Changes With Both Drug and Behavior Therapy for Obsessive-Compulsive Disorder
Arch Gen Psychiatry, September 1, 1992; 49(9): 681 - 689.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
C. A. Tamminga, G. K. Thaker, R. Buchanan, B. Kirkpatrick, L. D. Alphs, T. N. Chase, and W. T. Carpenter
Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome
Arch Gen Psychiatry, July 1, 1992; 49(7): 522 - 530.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
B. Szelies, K. Herholz, G. Pawlik, H. Karbe, I. Hebold, and W.-D. Heiss
Widespread Functional Effects of Discrete Thalamic Infarction
Arch Neurol, February 1, 1991; 48(2): 178 - 182.
[Abstract] [PDF]

Home page
 Vasc MedHome page
D. C. Costa
Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool
Vascular Medicine, September 1, 1990; 1(2): 179 - 201.
[PDF]

Home page
 Arch NeurolHome page
V. A. Holthoff, J. Sandmann, G. Pawlik, R. Schroder, and W.-D. Heiss
Positron Emission Tomography in Creutzfeldt-Jakob Disease
Arch Neurol, September 1, 1990; 47(9): 1035 - 1038.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
E. D. London, N. G. Cascella, D. F. Wong, R. L. Phillips, R. F. Dannals, J. M. Links, R. Herning, R. Grayson, J. H. Jaffe, and H. N. Wagner Jr
Cocaine-Induced Redoppuction of Glucose Utilization in Human Brain: A Study Using Positron Emission Tomography and [Fluorine 18]-Fluorodeoxyglucose
Arch Gen Psychiatry, June 1, 1990; 47(6): 567 - 574.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
E. D. London, E. P. M. Broussolle, J. M. Links, D. F. Wong, N. G. Cascella, R. F. Dannals, M. Sano, R. Herning, F. R. Snyder, L. R. Rippetoe, et al.
Morphine-Induced Metabolic Changes in Human Brain: Studies With Positron Emission Tomography and [Fluorine 18]Fluorodeoxyglucose
Arch Gen Psychiatry, January 1, 1990; 47(1): 73 - 81.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
G. W. Small, D. E. Kuhl, W. H. Riege, D. G. Fujikawa, J. W. Ashford, E. J. Metter, and J. C. Mazziotta
Cerebral Glucose Metabolic Patterns in Alzheimer's Disease: Effect of Gender and Age at Dementia Onset
Arch Gen Psychiatry, June 1, 1989; 46(6): 527 - 532.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
L. R. Baxter Jr, J. M. Schwartz, M. E. Phelps, J. C. Mazziotta, B. H. Guze, C. E. Selin, R. H. Gerner, and R. M. Sumida
Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of Depression
Arch Gen Psychiatry, March 1, 1989; 46(3): 243 - 250.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
M. Huber, K. Herholz, G. Pawlik, B. Szelies, R. Jurgens, and W.-D. Heiss
Cerebral Glucose Metabolism in the Course of Subacute Sclerosing Panencephalitis
Arch Neurol, January 1, 1989; 46(1): 97 - 100.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
H. Szechtman, C. Nahmias, E. S. Garnett, G. Firnau, G. M. Brown, R. D. Kaplan, and J. M. Cleghorn
Effect of Neuroleptics on Altered Cerebral Glucose Metabolism in Schizophrenia
Arch Gen Psychiatry, June 1, 1988; 45(6): 523 - 532.
[Abstract] [PDF]

Home page
 JAMAHome page
J. M. Schwartz, L. R. Baxter Jr, J. C. Mazziotta, R. H. Gerner, and M. E. Phelps
The Differential Diagnosis of Depression: Relevance of Positron Emission Tomography Studies of Cerebral Glucose Metabolism to the Bipolar-Unipolar Dichotomy
JAMA, September 11, 1987; 258(10): 1368 - 1374.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
R. E. Gur, S. M. Resnick, A. Alavi, R. C. Gur, S. Caroff, R. Dann, F. L. Silver, A. J. Saykin, J. B. Chawluk, M. Kushner, et al.
Regional Brain Function in Schizophrenia: I. A Positron Emission Tomography Study
Arch Gen Psychiatry, February 1, 1987; 44(2): 119 - 125.
[Abstract] [PDF]

Home page
 ANGIOLOGYHome page
M. Kushner and A. Alavi
Viscerally Induced Cutaneous Vasospasm
Angiology, August 1, 1985; 36(8): 522 - 527.
[Abstract] [PDF]

Home page
 ScienceHome page
M. Phelps and J. Mazziotta
Positron emission tomography: human brain function and biochemistry
Science, May 17, 1985; 228(4701): 799 - 809.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
T. N. Chase, P. Fedio, N. L. Foster, R. Brooks, G. Di Chiro, and L. Mansi
Wechsler Adult Intelligence Scale Performance: Cortical Localization by Fluorodeoxyglucose F18-Positron Emission Tomography
Arch Neurol, December 1, 1984; 41(12): 1244 - 1247.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
N. R. CUTLER, R. DUARA, H. CREASEY, C. L. GRADY, J. V. HAXBY, M. B. SCHAPIRO, and S. I. RAPOPORT
Brain Imaging: Aging and Dementia
Ann Intern Med, September 1, 1984; 101(3): 355 - 369.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
G. G. Celesia, R. E. Polcyn, J. E. Holden, R. J. Nickles, R. A. Koeppe, and S. J. Gatley
Determination of Regional Cerebral Blood Flow in Patients With Cerebral Infarction: Use of Fluoromethane Labeled With Fluorine 18 and Positron Emission Tomography
Arch Neurol, March 1, 1984; 41(3): 262 - 267.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
T. Farkas, A. P. Wolf, J. Jaeger, J. D. Brodie, D. R. Christman, J. S. Fowler, R. R. MacGregor, M. J. deLeon, P. deFina, A. Goldman, et al.
Regional Brain Glucose Metabolism in Chronic Schizophrenia: A Positron Emission Transaxial Tomographic Study
Arch Gen Psychiatry, March 1, 1984; 41(3): 293 - 300.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
D. F. Benson, D. E. Kuhl, R. A. Hawkins, M. E. Phelps, J. L. Cummings, and S. Y. Tsai
The Fluorodeoxyglucose 18F Scan in Alzheimer's Disease and Multi-infarct Dementia
Arch Neurol, November 1, 1983; 40(12): 711 - 714.
[Abstract] [PDF]

Home page
 ScienceHome page
H. Wagner Jr, H. Burns, R. Dannals, D. Wong, B Langstrom, T Duelfer, J. Frost, H. Ravert, J. Links, S. Rosenbloom, et al.
Imaging dopamine receptors in the human brain by positron tomography
Science, September 23, 1983; 221(4617): 1264 - 1266.
[Abstract] [PDF]

Home page
 ScienceHome page
J. Coyle, D. Price, and M. DeLong
Alzheimer's disease: a disorder of cortical cholinergic innervation
Science, March 11, 1983; 219(4589): 1184 - 1190.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
M. E. PHELPS, H. R. SCHELBERT, and J. C. MAZZIOTTA
Positron Computed Tomography for Studies of Myocardial and Cerebral Function
Ann Intern Med, March 1, 1983; 98(3): 339 - 359.
[Abstract] [PDF]

Home page
 ScienceHome page
K. Frey and B. Agranoff
Barbiturate-enhanced detection of brain lesions by carbon-14-labeled 2-deoxyglucose autoradiography
Science, February 18, 1983; 219(4586): 879 - 881.
[Abstract] [PDF]

Home page
 ScienceHome page
J Engel Jr, D. Kuhl, and M. Phelps
Patterns of human local cerebral glucose metabolism during epileptic seizures
Science, October 1, 1982; 218(4567): 64 - 66.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
J. ENGEL Jr., A. S. TROUPIN, P. H. CRANDALL, M. B. STERMAN, and C. G. WASTERLAIN
Recent Developments in the Diagnosis and Therapy of Epilepsy
Ann Intern Med, October 1, 1982; 97(4): 584 - 598.
[Abstract] [PDF]

Home page
 ScienceHome page
R. Gur, R. Gur, W. Obrist, J. Hungerbuhler, D Younkin, A. Rosen, B. Skolnick, and M Reivich
Sex and handedness differences in cerebral blood flow during rest and cognitive activity
Science, August 13, 1982; 217(4560): 659 - 661.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
M. S. Buchsbaum, D. H. Ingvar, R. Kessler, R. N. Waters, J. Cappelletti, D. P. van Kammen, A. C. King, J. L. Johnson, R. G. Manning, R. W. Flynn, et al.
Cerebral Glucography With Positron Tomography: Use in Normal Subjects and in Patients With Schizophrenia
Arch Gen Psychiatry, March 1, 1982; 39(3): 251 - 259.
[Abstract] [PDF]

Home page
 ScienceHome page
G. L. Brownell, T. F. Budinger, P. C. Lauterbur, and P. L. MCGeer
Positron Tomography and Nuclear Magnetic Resonance Imaging
Science, February 5, 1982; 215(4533): 619 - 626.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
R. H. Ackerman, J. A. Correia, N. M. Alpert, J.-C. Baron, A. Gouliamos, J. C. Grotta, G. L. Brownell, and J. M. Taveras
Positron Imaging in Ischemic Stroke Disease Using Compounds Labeled With Oxygen 15: Initial Results of Clinicophysiologic Correlations
Arch Neurol, September 1, 1981; 38(9): 537 - 543.
[Abstract] [PDF]

Home page
 JAMAHome page
L. M. Freeman
Nuclear Medicine: The Radiologist's View
JAMA, June 5, 1981; 245(21): 2203 - 2205.
[Abstract] [PDF]

Home page
 ScienceHome page
M. Phelps, D. Kuhl, and J. Mazziota
Metabolic mapping of the brain's response to visual stimulation: studies in humans
Science, March 27, 1981; 211(4489): 1445 - 1448.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
C. Caraco, L. Aloj, L.-Y. Chen, J. Y. Chou, and W. C. Eckelman
Cellular Release of [18F]2-Fluoro-2-deoxyglucose as a Function of the Glucose-6-phosphatase Enzyme System
J. Biol. Chem., June 9, 2000; 275(24): 18489 - 18494.
[Abstract] [Full Text] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1979 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.